In this study, in which we searched for the presence of GR polymorphisms that yield high sensitivity to GCs, we found that carriers of the BclI polymorphism were more prone to side effects of GCs like Cushingoid changes, dyspepsia, and depression symptoms for the first time in the literature as far as we know. The gene discussed is NR3C1; the disease is major depressive disorder.